Docstoc

Retina Institute Japan and Dainippon Sumitomo Pharma Form a Capital Alliance Towards the Development of Nobel Prize Winning iPS Cell Technology

Document Sample
Retina Institute Japan and Dainippon Sumitomo Pharma Form a Capital Alliance Towards the Development of Nobel Prize Winning iPS Cell Technology Powered By Docstoc
					
				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:0
posted:3/29/2013
language:Japanese
pages:2
Description: TOKYO--(BUSINESS WIRE)--Retina Institute Japan K.K. (RIJ) (Headquarters: Fukuoka, Japan; President: Hardy T S Kagimoto, MD) and Dainippon Sumitomo Pharma Co., Ltd. (DSP) (Headquarters: Osaka, Japan; President: Masayo Tada) announce today that the two companies signed an agreement (Agreement) that DSP invests into RIJ to discuss alliance to put iPS cell technology to practical use. Under the Agreement, DSP has subscribed for 1.5 billion JPY of third party allocation of shares by RIJ. DSP will exc
EON: Enhanced Online News EON: Enhanced Online News http://eon.businesswire.com
About At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.